▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

American International Group Q4 22 Earnings Conference Call At 8:30 AM ET

By RTTNews Staff Writer ✉ | Published: 2/16/2023 6:02 AM ET

American International Group, Inc. (AIG) will host a conference call at 8:30 AM ET on Feb. 16, 2023, to discuss Q4 22 earnings results.

To access the live webcast, log on to https://www.aig.com/investor-relations/webcasts-and-presentations

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Read More

COVID-19: Drugs in Development

RELATED NEWS

AIG To Sell Validus Re To RenaissanceRe Holdings For $2.985 Bln

American International Group, Inc. Profit Retreats In Q1

American International Group Q1 23 Earnings Conference Call At 8:30 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Macy's, Dollar General Q1 Profits Decline

FDA Warns Retailers Against Illegal Sales Of Disposable E-cigarettes

Tillamook Recalls Certain Waffle Cone Swirl Ice Cream Packaged In Chocolate Peanut Butter Carton

Mattel Unveils New Barbie The Movie Collection

Rudolph's OnYums Onion Flavored Rings Sold At Dollar Tree Recalled

Krispy Kreme, Dunkin' To Offer Free Donuts On National Doughnut Day

Cricket Creek Farm Recalls Sophelise And Tobasi Cheeses

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

U-Haul Holding Shares Down On Lower Earnings In Q4

Seagen To Be Acquired By Pfizer For $43 Bln

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

Magnachip To Spin-off Display And Power Businesses Into Separate Entities

Macy's Q1 Profit Down, But Beats Estimates; Cuts Annual Earnings Guidance Below View - Update

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Trevena Achieves Listing Compliance On Nasdaq

ACI Worldwide Appoints Thomas Warsop As New CEO

Alterity Therapeutics Granted Initial Approval For Phase 2 Clinical Trial Of ATH434

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

NatWest Completes Sale Of EUR 55.2 Mln Of Shares In Permanent TSB

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Dollar General Q1 Results Miss Estimates, Cuts FY23 View; Stock Down In Premarket

Balfour Beatty's JV Gammon Bags HK$3.7 Bln Contract In Hong Kong

JBT To Sell Its AeroTech Business To Oshkosh - Quick Facts

Advance Auto Parts Announces Retreat In Q1 Bottom Line

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Chewy Q1 Results Beat Estimate; Shares Jump 11% After Hours

Dollar General Down In Pre-market On Q1 Results, Outlook

Macy's, Dollar General Q1 Profits Decline

TotalEnergies Renews OML130 Deep Offshore License In Nigeria